$256 Million is the total value of UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's 18 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 57.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ZIOP | New | ZIOPHARM ONCOLOGY INC | $126,248,000 | – | 11,722,163 | +100.0% | 49.23% | – |
| XON | New | INTREXON CORPORATION | $95,281,000 | – | 2,100,085 | +100.0% | 37.15% | – |
| WPZ | New | WILLIAMS PARTNERS LPlp - public equity | $8,502,000 | – | 172,732 | +100.0% | 3.32% | – |
| VOO | Buy | VANGUARD 500 INDEX FUNDetfs | $3,118,000 | +3.1% | 16,482 | +2.6% | 1.22% | -84.5% |
| VEA | Buy | VANGUARD FTSE DEV MKTSetfs | $2,607,000 | +8.7% | 65,465 | +3.4% | 1.02% | -83.6% |
| VWO | Buy | VANGUARD MSCI EMERGING MKTSetfs | $2,484,000 | +5.5% | 60,789 | +3.4% | 0.97% | -84.1% |
| VOE | Buy | VANGUARD MID-CAP VALUE ETFetfs | $2,423,000 | +6.4% | 26,362 | +3.5% | 0.94% | -84.0% |
| VDE | Buy | VANGUARD ENERGY ETFetfs | $1,870,000 | +1.9% | 17,109 | +4.0% | 0.73% | -84.7% |
| GLD | Buy | SPDR GOLD TRUSTetfs | $1,753,000 | +3.2% | 15,422 | +3.2% | 0.68% | -84.4% |
| VNQ | Buy | VANGUARD REIT ETFetfs | $1,560,000 | +6.8% | 18,503 | +2.6% | 0.61% | -83.9% |
| VTAE | New | VITAE PHARMACEUTICALS INC | $130,000 | – | 11,100 | +100.0% | 0.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2015-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEXAS INSTRUMENTS INC | 41 | Q3 2023 | 31.2% |
| PORTLAND GENERAL ELECTRIC CO | 38 | Q3 2023 | 0.0% |
| LEXICON PHARMACEUTICALS INC | 33 | Q3 2023 | 1.7% |
| AEGLEA BIOTHERAPEUTICS INC | 27 | Q2 2023 | 11.0% |
| APOLLO ENDOSURGERY INC | 24 | Q1 2023 | 5.6% |
| PLX PHARMA INC | 23 | Q1 2023 | 1.7% |
| VANGUARD MSCI EMERGING MKTS | 22 | Q2 2019 | 10.3% |
| VANGUARD ENERGY ETF | 22 | Q2 2019 | 8.7% |
| VANGUARD S&P 500 ETF | 21 | Q3 2023 | 11.8% |
| VANGUARD MSCI EAFE ETF | 20 | Q2 2019 | 13.1% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Taysha Gene Therapies, Inc. | September 24, 2021 | 1,156,255 | 3.0% |
| ZIOPHARM ONCOLOGY INC | February 12, 2016 | 9 | 0.0% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-06-12 |
| 4 | 2024-06-07 |
| 4/A | 2024-05-14 |
| 4 | 2024-05-01 |
| 3 | 2024-04-30 |
| 13F-HR | 2024-04-30 |
| 144 | 2024-04-29 |
| SC 13G | 2024-03-05 |
| 13F-HR | 2024-02-28 |
| SC 13G | 2024-02-14 |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.